➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for fluoruracil

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for fluoruracil?

fluoruracil is an investigational drug.

There have been 26 clinical trials for fluoruracil. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2007.

The most common disease conditions in clinical trials are Breast Neoplasms, Stomach Neoplasms, and Colorectal Neoplasms. The leading clinical trial sponsors are Hellenic Oncology Research Group, University Hospital of Crete, and AHS Cancer Control Alberta.

Recent Clinical Trials for fluoruracil
Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm PatientsGruppo Oncologico Italiano di Ricerca ClinicaPhase 2
First-line Therapy in Metastatic PDACLudwig-Maximilians - University of MunichPhase 2
Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract CancerChungnam National University HospitalPhase 2

See all fluoruracil clinical trials

Clinical Trial Summary for fluoruracil

Top disease conditions for fluoruracil
Top clinical trial sponsors for fluoruracil

See all fluoruracil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.